At a Glance
| Detail | Antidote | Nexl |
|---|---|---|
| Category | Practice Mgmt | Practice Mgmt |
| Total raised | $5M | $27M |
| Rounds tracked | 1 | 2 |
| Latest round | Seed, $5M · Jan 2026 | Series B, $23M · Oct 2025 |
| Last valuation | Not disclosed | Not disclosed |
| Lead investors | Lakestar | Tidemark Capital, EVP |
| Built for | Large firms | Not disclosed |
| Headquarters | United Kingdom | Australia |
Funding, Side by Side
Antidote rounds
- Jan 2026Seed$5M
Nexl rounds
- Oct 2025Series B$23M
- Mar 2023Undisclosed$4M
Backed by both: The LegalTech Fund.
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Antidote or Nexl?
- Nexl has raised $27M in disclosed funding, compared with $5M for Antidote.
- Do Antidote and Nexl share investors?
- Yes. The LegalTech Fund backed both.
- What is Antidote best for?
- Antidote is AI billing compliance software that checks and corrects law firm time entries against client billing guidelines.
- What is Nexl best for?
- CRM and growth platform for law firms.
Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.